Anup singh
Windlas Biotech Limited IPO [INITIAL PUBLIC OFFERING] Detail
About The Windlas Biotech Limited
The Company was incorporated as ‘Windlas Biotech Limited’ on February 19, 2001 at New Delhi as a public limited company under the Companies Act, 1956 and was granted a certificate of incorporation by the Assistant Registrar of Companies, National Capital Territory of Delhi and Haryana, at New Delhi (“RoC Delhi”). The Company received the
certificate for commencement of business on March 5, 2001 from the RoC Delhi. The registered office of the Company was shifted from the state of Delhi to the state of Uttarakhand pursuant to a special resolution passed by the Shareholders on August 22, 2009. The alteration with respect to the place of the registered office was confirmed by the order of the Company Law Board, New Delhi on August 5, 2010 and a fresh certificate of registration was issued by the Registrar of Companies, Uttar Pradesh and Uttarakhand at Kanpur on February 18, 2011.
Subsequently, the Company was converted into a private limited company pursuant to a special resolution passed by the Shareholders on March 30, 2016 and a fresh certificate of incorporation consequent upon conversion and change of name to ‘Windlas Biotech Private Limited’ was granted by the Registrar of Companies, Uttarakhand at Kanpur on July 22, 2016. The Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by the Shareholders on April 3, 2021, and the name of the Company was changed to ‘Windlas Biotech Limited’. A fresh certificate of incorporation dated April 15, 2021, consequent upon change of name on conversion to a public limited company was granted by the Registrar of Companies, Uttarakhand at Dehradun (“RoC”).
Amongst the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (“CDMO”) industry in India in terms of revenue
Registered Office: 40/1, Mohabewala Industrial Area, Dehradun 248 110, Uttarakhand, India; Tel: +91 135 6608000
Corporate Office: 705-706, Vatika Professional Point, Sector-66, Golf Course Extension Road, Gurgaon 122 001, Haryana, India; Tel: +91 124 2821030
Website: www.windlasbiotech.com;
Contact Person: Ananta Narayan Panda, Company Secretary and Compliance Officer;
E-mail: grievance@windlasbiotech.com;
Corporate Identity Number: U74899UR2001PLC033407
Company Promoters
ASHOK KUMAR WINDLASS
HITESH WINDLASS
MANOJ KUMAR WINDLASS AND AKW WBL FAMILY PRIVATE TRUST
Company Financials
Summary of Restated Consolidated Financial Information
For the year/period ended ( ₹ in Million)
| Particulars | |||
|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Revenue | 4,306.95 | 3,313.39 | 3,115.25 |
| Profit After Tax | 155.70 | 162.13 | 638.22 |
| Total Asset | 2,961.23 | 3,384.88 | 2,981.80 |
Windlas Biotech Limited – IPO Details
IPO Details
| Issue Open Date | 4 Aug 2021 |
| Issue Close Date | 6 Aug 2021 |
| Issue Type | Book Built |
| Face Value | ₹ 5 per equity share |
| IPO/Issue Price | ₹ 448 to ₹ 460 per equity share |
| Market Lot | 30 Shares |
| Min Order Quantity | 30 Shares |
| Listing At | BSE, NSE |
IPO/ Issue Time Line [Tentative]
Issue Open Date
Issue Close Date
Basis of Allotment Date
Initiation of Refunds
Credit of Shares to Demat Account
IPO Listing Date
Objects of the Issue
The Company proposes to utilize the Net Proceeds from the Offer towards funding the following objects:
1. Purchase of equipment required for (i) capacity expansion of our existing facility at Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
2. Funding incremental working capital requirements of our Company;
3. Repayment/prepayment of certain of our borrowings; and
4. General corporate purposes
